Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Trends Mol Med ; 26(6): 529-531, 2020 06.
Article in English | MEDLINE | ID: covidwho-1720652


The current coronavirus disease 2019 (COVID-19) pandemic is rapidly spreading around the world. The first doctor to report this new disease was an ophthalmologist: this exemplifies the role of ophthalmologists in an infectious disease pandemic. Here we review how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the eye and discuss implications for ophthalmologists.

Betacoronavirus/isolation & purification , Conjunctiva/virology , Conjunctivitis, Viral/virology , Coronavirus Infections/complications , Pneumonia, Viral/complications , COVID-19 , Conjunctivitis, Viral/epidemiology , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Eye/virology , Humans , Ophthalmologists , Ophthalmology , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , SARS-CoV-2
Eur J Ophthalmol ; 31(2): NP4-NP7, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-947912


The Coronavirus disease 2019 (COVID-19) outbreak has imposed the adoption of strategies to limit the risk of contagion for cancer patients without compromising their healthcare. As well as cancers of other sites, the treatment of certain ocular and periocular malignancies is considered non-deferrable and should proceed despite the pandemic. Delays in treatment of these patients may result in negative outcomes. Herein, we provide some practical considerations deriving from our experience at the Ocular Oncology Unit of Careggi University Hospital (Florence, Italy).

COVID-19/epidemiology , Delivery of Health Care/organization & administration , Eye Neoplasms/diagnosis , Eye Neoplasms/therapy , Hospitals, University/organization & administration , Medical Oncology/organization & administration , SARS-CoV-2 , Disease Outbreaks , Humans , Italy/epidemiology
Eur J Ophthalmol ; 31(5): 2252-2258, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-729486


PURPOSE: To compare the number of eye surgical procedures performed in Italy during the first month of lockdown with those performed in the same period in 2019. METHODS: Review of the surgical procedures performed from 10 March to 9 April 2019 and from 10 March to 9 April 2020 (the first month of lockdown because of the COVID-19 outbreak) at six academic institutional centers of Italy. A distinction was made between urgent procedures: any trauma repairment, trabeculectomy/drainage implant for glaucoma, any operation for rhegmatogenous retinal detachment (RRD) repair, pars plana vitrectomy (PPV) for vitreous hemorrhage (VH), macular hole, or retained lens fragments; elective procedures: corneal transplant, phacoemulsification for cataract extraction, silicone oil removal, and PPV for epiretinal membrane; and intravitreal injections (either anti-vascular endothelial growth factor [VEGF] or dexamethasone) to treat exudative maculopathies. The main outcome measure was the rate of reduction in urgent and elective surgeries performed. RESULTS: Overall, 3624 and 844 surgical procedures were performed from 10 March to 9 April 2019 and from 10 March to 10 April 2020, respectively (-76.7% in 2020 compared to 2019, p < 0.0001). Urgent and elective surgical procedures and intravitreal injections of anti-VEGF drugs or dexamethasone reduced significantly in 2020 in comparison to 2019 (p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections). CONCLUSION: A significant reduction in the rate of urgent and elective surgeries and intravitreal injections was recorded during the first month of lockdown compared to the same period in 2019. With this analysis, the authors hope to provide some preliminary insights about the consequences of lockdown for the eyecare system in Italy.

COVID-19 , Retinal Detachment , Communicable Disease Control , Humans , Retinal Detachment/surgery , Retrospective Studies , SARS-CoV-2 , Vitrectomy